{"acquisitions":[],"changes":[],"country":"FR","description":"Tafalgie Therapeutics develops non-opioid painkillers based on the endogenous protein TAFA4 that modulates pain signaling. It targets patients with acute and chronic pain, including postoperative pain. Its disease-modifying approach aims to relieve pain without tolerance or dependence.","domain":"tafalgie.fr","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":43.296399,"lng":5.377789,"location":"Marseille, France","multiples":[],"name":"Tafalgie Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2700000,"connectionsAmong":[],"currency":"EUR","date":"2023-07-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"tafalgie-fr-2023-07-01-grant","source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"tafalgie-fr","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"tafalgie.fr","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tafalgie.fr"},{"fact":"description","publisher":"tafalgie.fr","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tafalgie.fr"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["WordPress 6.9.4","WordPress Block Editor","LiteSpeed","PHP","MySQL","jquery 3.7.1","bootstrap 3.4.2"],"totalRaisedUsd":2700000,"traction":[],"updatedAt":"2026-05-08","valuations":[]}